Antonio Liras

Summary

Publications

  1. ncbi [Smoking habit: physiopathology and prevention]
    Antonio Liras
    Departamento de Fisiologia, Facultad de Biologia, Universidad Complutense de Madrid, Espana
    Rev Invest Clin 59:278-89. 2007
  2. ncbi Disorder in clotting pattern after antiretroviral treatment with emtricitabine in an HIV-positive haemophiliac patient
    Antonio Liras
    Scientific Commission of the Royal Foundation Victoria Eugenia of Haemophilia, Madrid, Spain
    Clin Drug Investig 27:857-9. 2007
  3. ncbi Recombinant proteins in therapeutics: haemophilia treatment as an example
    Antonio Liras
    Department of Physiology, Faculty of Biology, Complutense University of Madrid, Spain
    Int Arch Med 1:4. 2008
  4. ncbi The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?
    Antonio Liras
    Department of Physiology, Biology School, Universidad Complutense of Madrid, Spain
    Int Arch Med 1:9. 2008
  5. ncbi Gene therapy for haemophilia...yes, but...with non-viral vectors?
    A Liras
    Department of Physiology, Biology School, Universidad Complutense of Madrid, Madrid, Spain
    Haemophilia 15:811-6. 2009
  6. ncbi Bioethics in biomedicine in the context of a global higher education area
    Antonio Liras
    Department of Physiology, School of Biological Sciences, Complutense University of Madrid, Spain
    Int Arch Med 3:10. 2010
  7. ncbi Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects
    Antonio Liras
    Department of Physiology, School of Biological Sciences, Complutense University of Madrid, Spain
    J Transl Med 8:131. 2010
  8. ncbi Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    A Liras
    Department of Physiology, Biology School, Universidad Complutense of Madrid, Spain
    Thromb Res 128:8-13. 2011
  9. ncbi Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain
    Javier Batlle
    Scientific Committee, Royal Foundation Victoria Eugenia, Madrid, Spain
    Blood Coagul Fibrinolysis 19:333-40. 2008

Detail Information

Publications9

  1. ncbi [Smoking habit: physiopathology and prevention]
    Antonio Liras
    Departamento de Fisiologia, Facultad de Biologia, Universidad Complutense de Madrid, Espana
    Rev Invest Clin 59:278-89. 2007
    ....
  2. ncbi Disorder in clotting pattern after antiretroviral treatment with emtricitabine in an HIV-positive haemophiliac patient
    Antonio Liras
    Scientific Commission of the Royal Foundation Victoria Eugenia of Haemophilia, Madrid, Spain
    Clin Drug Investig 27:857-9. 2007
    ....
  3. ncbi Recombinant proteins in therapeutics: haemophilia treatment as an example
    Antonio Liras
    Department of Physiology, Faculty of Biology, Complutense University of Madrid, Spain
    Int Arch Med 1:4. 2008
    ....
  4. ncbi The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?
    Antonio Liras
    Department of Physiology, Biology School, Universidad Complutense of Madrid, Spain
    Int Arch Med 1:9. 2008
    ..To face these new challenges we need innovative prevention strategies...
  5. ncbi Gene therapy for haemophilia...yes, but...with non-viral vectors?
    A Liras
    Department of Physiology, Biology School, Universidad Complutense of Madrid, Madrid, Spain
    Haemophilia 15:811-6. 2009
    ..This may more readily win acceptance among both patients and haematologists because fatal events in the past due to HIV/HCV infection may constrain the implementation of viruses as vectors...
  6. ncbi Bioethics in biomedicine in the context of a global higher education area
    Antonio Liras
    Department of Physiology, School of Biological Sciences, Complutense University of Madrid, Spain
    Int Arch Med 3:10. 2010
    ....
  7. ncbi Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects
    Antonio Liras
    Department of Physiology, School of Biological Sciences, Complutense University of Madrid, Spain
    J Transl Med 8:131. 2010
    ....
  8. ncbi Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    A Liras
    Department of Physiology, Biology School, Universidad Complutense of Madrid, Spain
    Thromb Res 128:8-13. 2011
    ..Because to date there are not relevant results for phenotypic correction in haemophilia, iPSCs technology could represent a potential alternative based on cellular therapy...
  9. ncbi Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain
    Javier Batlle
    Scientific Committee, Royal Foundation Victoria Eugenia, Madrid, Spain
    Blood Coagul Fibrinolysis 19:333-40. 2008
    ..Essentially, it suggests that a gradual switch to recombinant concentrates may be a beneficial decision for patients with haemophilia and for the National Health Service...